Hans Bo Göran Wessman
Vorsitzender bei Protem Wessman AB
Vermögen: 7 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Hans Bo Göran Wessman
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 | |
Itin Holding AB
3
| Private Company | 3 | |
Protem Företagsförvaltning AB
2
| Private Company | 2 | |
Protem Wessman AB
2
| Subsidiary | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hans Bo Göran Wessman
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SAAB AB | Aerospace & Defense | Director/Board Member | |
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
MedCore AB
 MedCore AB Medical SpecialtiesHealth Technology MedCore AB operates as a medical technology company. It engages in the distribution of medical products. The company was founded in 2000 and is headquartered in Kista, Sweden. | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
| SECTRA AB | Packaged Software | Director/Board Member | |
| BIOTAGE AB | Medical Specialties | Director of Finance/CFO | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Consultant / Advisor | |
Biotage GB Ltd.
 Biotage GB Ltd. Medical SpecialtiesHealth Technology Part of Biotage AB, Biotage GB Ltd. is a British company that manufactures and distributes chromatography accessories, consumables, and instruments. The company is based in Cardiff, UK. Biotage GB was acquired by Argonaut Technologies, Inc. on February 20, 2002 for $17.82 million. | Medical Specialties | Director/Board Member | |
| MEDCAP AB | Medical Specialties | Director/Board Member | |
| Stockholm School of Economics | College/University | Graduate Degree | |
| University of Uppsala | College/University | Masters Business Admin Doctorate Degree | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| INVISIO AB | Telecommunications Equipment | Director/Board Member | |
| Royal Institute of Technology | College/University | Graduate Degree Graduate Degree | |
| University of Lund | College/University | Doctorate Degree Masters Business Admin Corporate Officer/Principal Graduate Degree | |
| University of Gothenburg | College/University | Undergraduate Degree Corporate Officer/Principal | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Private Equity Investor | |
| BONESUPPORT HOLDING AB | Medical Specialties | Director/Board Member | |
MIP Technologies AB
 MIP Technologies AB Miscellaneous Commercial ServicesCommercial Services MIP Technologies is a biotechnology company working at the boundary of chemistry and materials science. The company develops solutions in the Separations field using proprietary Molecularly Imprinted Polymer (MIP) technology and other novel polymer chemistries. Its pipeline of solid phase extraction (SPE) phases, based on molecular imprinting and marketed under the Supelco Sigma Aldrich brand name, SupelMIP, provides clever solutions to difficult analytical extraction problems. Its custom OPUS phases which use both molecular imprinting and smart variations of conventional polymer chemistry, provide unmatched preparative and process scale separation solutions for both small molecules and peptides. | Miscellaneous Commercial Services | Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| EQL PHARMA AB | Pharmaceuticals: Generic | Founder Director/Board Member Director/Board Member | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member | |
| NELLY GROUP AB | Internet Retail | Director/Board Member | |
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Director/Board Member | |
| Flood Vision, Inc. | Director/Board Member | ||
BONE SUPPORT AB
 BONE SUPPORT AB Medical SpecialtiesHealth Technology BONE SUPPORT AB manufactures orthopedic supplies and equipment. Its products include cerament bone void filler, cerament G with gentamicin, cerament V with vancomycin. The company was founded by Lars Ake Alvar Lidgren in 1999 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member | |
Karo Pharma Med AB
 Karo Pharma Med AB Pharmaceuticals: MajorHealth Technology Karo Pharma Med AB develops, manufactures, and markets new medical technology products and drugs for infectious diseases. It also engages I research and development. The company was founded by Nils Krister Tano in 2008 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Director of Finance/CFO Director/Board Member | |
SARomics Biostructures AB
 SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | Biotechnology | Director/Board Member | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| INTELLEGO TECHNOLOGIES AB | Electronic Components | Director/Board Member Chairman | |
| ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Director/Board Member | |
| TC TECH SWEDEN AB (PUBL) | Electrical Products | Director/Board Member Director/Board Member | |
| Neuronano AB | Chairman Director/Board Member | ||
| Vaxonia AB | Director/Board Member | ||
| CEMU Bioteknik AB | Corporate Officer/Principal | ||
| FRILL HOLDING B | Food: Major Diversified | Director/Board Member Chief Executive Officer | |
| PAXMAN AB | Medical Specialties | Chairman Director/Board Member | |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Schweden | 38 |
| Vereinigte Staaten | 7 |
| Vereinigtes Königreich | 5 |
Sektoral
| Health Technology | 24 |
| Commercial Services | 6 |
| Consumer Services | 6 |
| Electronic Technology | 4 |
| Finance | 4 |
Operativ
| Director/Board Member | 202 |
| Chairman | 61 |
| Corporate Officer/Principal | 48 |
| Chief Executive Officer | 31 |
| Independent Dir/Board Member | 23 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Hans Bo Göran Wessman
- Unternehmensverbindungen
